Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Dunphy · SciRah

Researcher profile · Semantic Scholar

M. Dunphy

Share profile

M. Dunphy — researcher profile on SciRah

h-index: 29
Works: 105
Citations: 3,200

Most-cited papers

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo
S. Venneti, M. Dunphy, Hanwen Zhang, K. Pitter +16 more
2015Science Translational Medicine299 citations Open access
Semantic Scholar
The epichaperome is an integrated chaperome network that facilitates tumour survival
Anna Rodina, Tai Wang, P. Yan, E. D. Gomes +39 more
2016Nature272 citations Open access
Semantic Scholar
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplant.
S. Prockop, E. Doubrovina, Stephanie D. Suser, G. Heller +29 more
2020Journal of Clinical Investigation197 citations Open access
Semantic Scholar
Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions
K. Jhaveri, Stefan O. Ochiana, M. Dunphy, J. Gerecitano +7 more
2014Expert Opinion on Investigational Drugs168 citations Open access
Semantic Scholar
MIRD Pamphlet No. 24: Guidelines for Quantitative 131I SPECT in Dosimetry Applications
Y. Dewaraja, M. Ljungberg, A. Green, P. Zanzonico +9 more
2013Journal of Nuclear Medicine144 citations Open access
Semantic Scholar
Non-invasive metabolic imaging of brain tumors in the era of precision medicine
Michelle M. Kim, A. Parolia, M. Dunphy, S. Venneti
2016Nature Reviews Clinical Oncology109 citations Open access
Semantic Scholar
MIRD Pamphlet No. 25: MIRDcell V2.0 Software Tool for Dosimetric Analysis of Biologic Response of Multicellular Populations
Behrooz Vaziri, Han Wu, A. Dhawan, Peicheng Du +9 more
2014Journal of Nuclear Medicine102 citations Open access
Semantic Scholar
In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of 18F-(2S,4R)-4-Fluoroglutamine.
M. Dunphy, J. Harding, S. Venneti, Hanwen Zhang +15 more
2018Radiology98 citations Open access
Semantic Scholar
Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET
M. Dunphy, J. Lewis
2009Journal of Nuclear Medicine98 citations Open access
Semantic Scholar
Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC
M. Hellmann, B. Nabet, H. Rizvi, A. Chaudhuri +31 more
2020Clinical Cancer Research96 citations Open access
Semantic Scholar
Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer
J. Cuaron, M. Dunphy, A. Rimner
2013Frontiers in Oncology96 citations Open access
Semantic Scholar
FDG-PET SUVmax Combined with IASLC/ATS/ERS Histologic Classification Improves the Prognostic Stratification of Patients with Stage I Lung Adenocarcinoma
K. Kadota, C. Colovos, Kei Suzuki, N. Rizk +7 more
2012Annals of Surgical Oncology96 citations Open access
Semantic Scholar
The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunction
M. C. Inda, Suhasini Joshi, Tai Wang, Alexander Bolaender +35 more
2020Nature Communications79 citations Open access
Semantic Scholar
A Phase I Dose-Escalation and Expansion Study of Telaglenastat in Patients with Advanced or Metastatic Solid Tumors
J. Harding, M. Telli, P. Munster, M. Voss +11 more
2021Clinical Cancer Research76 citations Open access
Semantic Scholar
Safety and tolerability of increasing doses of CB-839, a first-in-class, orally administered small molecule inhibitor of glutaminase, in solid tumors.
J. Harding, M. Telli, P. Munster, M. Le +10 more
201558 citations
Semantic Scholar
Paradigms for precision medicine in epichaperome cancer therapy
N. Pillarsetty, K. Jhaveri, Tony Taldone, Eloisi Caldas-Lopes +29 more
2019Cancer Cell54 citations Open access
Semantic Scholar
18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors
L. Michaud, B. Beattie, T. Akhurst, M. Dunphy +7 more
2019European Journal of Nuclear Medicine and Molecular Imaging53 citations Open access
Semantic Scholar
A Phase 1 Trial of MLN0128 (sapanisertib) and CB-839 HCl (telaglenastat) in Advanced NSCLC Patients (NCI 10327): Rationale and Study Design
J. Riess, P. Frankel, D. Shackelford, M. Dunphy +11 more
2020Clinical Lung Cancer50 citations Open access
Semantic Scholar
Adaptive neoadjuvant chemotherapy guided by 18F-FDG-PET in resectable non-small-cell lung cancers: the NEOSCAN trial
J. Chaft, M. Dunphy, J. Naidoo, W. Travis +7 more
2015Journal of Thoracic Oncology45 citations Open access
Semantic Scholar
Preoperative Consolidation-to-Tumor Ratio and SUVmax Stratify the Risk of Recurrence in Patients Undergoing Limited Resection for Lung Adenocarcinoma ≤2 cm
J. Nitadori, A. Bograd, E. A. Morales, N. Rizk +4 more
2013Annals of Surgical Oncology45 citations Open access
Semantic Scholar
Sex Differences in Brain Tumor Glutamine Metabolism Reveal Sex-Specific Vulnerabilities to Treatment
Jasmin Sponagel, Jill K. Jones, C. Frankfater, Shan-Shan Zhang +17 more
2021bioRxiv41 citations Open access
Semantic Scholar
Chaperome heterogeneity and its implications for cancer study and treatment
Tai Wang, Anna Rodina, M. Dunphy, A. Corben +4 more
2018Journal of Biological Chemistry41 citations Open access
Semantic Scholar
Safety and feasibility of PARP1/2 imaging with 18F-PARPi in patients with head and neck cancer
H. Schöder, Paula Demétrio De Souza França, Reiko Nakajima, E. Burnazi +13 more
2020Clinical Cancer Research39 citations Open access
Semantic Scholar
Primary results of NRG-RTOG1106/ECOG-ACRIN 6697: A randomized phase II trial of individualized adaptive (chemo)radiotherapy using mid-treatment FDG-PET/CT in stage III NSCLC
F. Kong, Chen Hu, Daniel A. Pryma, Fenghai Duan +23 more
2024Journal of Clinical Oncology35 citations Open access
Semantic Scholar
Preclinical and first-in-human-brain-cancer applications of [18F]poly (ADP-ribose) polymerase inhibitor PET/MR
R. Young, Paula Demétrio De Souza França, Giacomo Pirovano, A. Piotrowski +16 more
2020medRxiv33 citations Open access
Semantic Scholar
High-SUVmax on FDG-PET indicates pleomorphic subtype in epithelioid malignant pleural mesothelioma: Supportive evidence to reclassify pleomorphic as non-epithelioid histology
K. Kadota, S. Kachala, J. Nitadori, Kei Suzuki +5 more
2012Journal of Thoracic Oncology32 citations Open access
Semantic Scholar
First-in-human imaging with [89Zr]Zr-DFO-SC16·56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate
S. Tendler, M. Dunphy, Matthew Agee, J. O'Donoghue +15 more
2024The Lancet Oncology30 citations Open access
Semantic Scholar
Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system
Alexander Bolaender, D. Zatorska, Hua-Zhong He, Suhasini Joshi +37 more
2021Nature Communications30 citations Open access
Semantic Scholar
Pharmacokinetic Assessment of 18F-(2S,4R)-4-Fluoroglutamine in Patients with Cancer
M. Grkovski, Reema Goel, S. Krebs, Kevin D Staton +4 more
2019Journal of Nuclear Medicine28 citations Open access
Semantic Scholar
Measuring Tumor Epichaperome Expression Using [124I] PU-H71 Positron Emission Tomography as a Biomarker of Response for PU-H71 Plus Nab-Paclitaxel in HER2-Negative Metastatic Breast Cancer.
K. Jhaveri, C. D. dos Anjos, Tony Taldone, Rui Wang +13 more
2020JCO Precision Oncology24 citations Open access
Semantic Scholar
Optimizing 90Y particle density improves outcomes after radioembolization
A. Maxwell, H. Mendoza, Matthew J. Sellitti, J. Camacho +10 more
2022Cardiovascular and Interventional Radiology23 citations Open access
Semantic Scholar
First-in-Human Trial of Epichaperome-Targeted Positron Emission Tomography in Cancer Patients
M. Dunphy, Christina Pressl, N. Pillarsetty, M. Grkovski +19 more
2020Clinical Cancer Research23 citations Open access
Semantic Scholar
Persistent Severe Hyperlactatemia and Metabolic Derangement in Lethal SDHB-Mutated Metastatic Kidney Cancer: Clinical Challenges and Examples of Extreme Warburg Effect
Chung-Han Lee, G. Gundem, William Lee, Ying-Bei Chen +13 more
2017JCO Precision Oncology22 citations Open access
Semantic Scholar
Prognostic Value of Pre radiotherapy 18F-FDG PET/CT Volumetrics in Limited-stage Small Cell Lung Cancer
Leonard T. Ong, M. Dunphy, A. Foster, K. Woo +7 more
2015Clinical Lung Cancer22 citations Open access
Semantic Scholar
Radiosynthesis of the iodine-124 labeled Hsp90 inhibitor PU-H71
Tony Taldone, D. Zatorska, Stefan O. Ochiana, P. Smith-Jones +8 more
2016Journal of labelled compounds & radiopharmaceuticals20 citations Open access
Semantic Scholar
In Vivo Microcartography & Subcellular Imaging of Tumor Angiogenesis: a Novel Platform for Translational Angiogenesis Research
M. Dunphy, D. Entenberg, R. Toledo-Crow, S. Larson
2009Microvascular Research20 citations Open access
Semantic Scholar
Lesion Absorbed Dose–Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy
M. Grkovski, Simone Krebs, Joseph A. O'Donoghue, Jonathan Kuten +11 more
2025Journal of Nuclear Medicine17 citations Open access
Semantic Scholar
Detection of Recurrent Pancreatic Cancer: Value of Second-Opinion Interpretations of Cross-Sectional Images by subspecialized radiologists
Sandra Huicochea Castellanos, G. Corrias, G. Ulaner, M. Dunphy +6 more
2018Abdominal Radiology17 citations Open access
Semantic Scholar
Imaging skeletal muscle volume, density, and FDG uptake before and after induction therapy for non-small cell lung cancer
M. Goncalves, S. Taylor, D. Halpenny, E. Schwitzer +8 more
2018Clinical Radiology16 citations Open access
Semantic Scholar
Phase I trial of the HSP-90 inhibitor PU-H71.
J. Gerecitano, S. Modi, R. Rampal, A. Drilon +15 more
201515 citations
Semantic Scholar
Treatment response and clinical outcomes of well differentiated high grade neuroendocrine tumors to lutetium-177 DOTATATE
Nitya P. Raj, K. Coffman, T. Le, R. Do +12 more
2022Neuroendocrinology14 citations Open access
Semantic Scholar
Value of Second Opinion Review of Outside Institution PET-CT examinations
G. Ulaner, L. Mannelli, M. Dunphy
2017Nuclear medicine communications14 citations Open access
Semantic Scholar
Coincidental presentations of ganglioneuroma and atypical perforated appendicitis detected by fluorodeoxyglucose positron emission tomography/computed tomography.
Yang Lu, J. Fox, M. Dunphy
2009Clinical Nuclear Medicine12 citations
Semantic Scholar
Using 124I-PU-H71 PET imaging to predict intratumoral concentration in patients on a phase I trial of PU-H71.
J. Gerecitano, S. Modi, D. Gajria, Tony Taldone +12 more
201311 citations
Semantic Scholar
The Unique Pharmacometrics of Small Molecule Therapeutic Drug Tracer Imaging for Clinical Oncology
M. Dunphy, N. Pillarsetty
2020Cancers10 citations Open access
Semantic Scholar
Distribution of FDG-avid nodes in esophageal cancer: implications for radiotherapy target delineation
B. García, K. Goodman, L. Cambridge, M. Dunphy +1 more
2015Radiation Oncology10 citations Open access
Semantic Scholar
Dosimetry of 18F-Labeled Tyrosine Kinase Inhibitor SKI-249380, a Dasatinib-Tracer for PET Imaging
M. Dunphy, P. Zanzonico, D. Veach, Romel Somwar +3 more
2012Molecular Imaging and Biology10 citations Open access
Semantic Scholar
Molecular imaging of atherosclerosis
M. Dunphy, H. W. Strauss
2008Current Cardiology Reports10 citations
Semantic Scholar
Value of [18F]-FDG positron emission tomography in patients with recurrent glioblastoma receiving bevacizumab
M. Graham, S. Krebs, T. Bale, Kwaku Domfe +5 more
2020Neuro-Oncology Advances8 citations Open access
Semantic Scholar
Pamphlet No . 24 : Guidelines for Quantitative 131 I SPECT in Dosimetry Applications
Y. Dewaraja, M. Ljungberg, A. Green, P. Zanzonico +9 more
20138 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Lewis×12
Invite
J. Lewis — researcher profile on SciRah
G. Chiosis×11
Invite
G. Chiosis — researcher profile on SciRah
P. Zanzonico×10
Invite
P. Zanzonico — researcher profile on SciRah
S. Lyashchenko×9
Invite
S. Lyashchenko — researcher profile on SciRah

×9

Invite

N. Pillarsetty — researcher profile on SciRah

Tony Taldone×9

Invite

Tony Taldone — researcher profile on SciRah

Invite

S. Modi — researcher profile on SciRah

Invite

S. Larson — researcher profile on SciRah

Invite

Anna Rodina — researcher profile on SciRah

J. Gerecitano×6

Invite

J. Gerecitano — researcher profile on SciRah

Invite

E. Burnazi — researcher profile on SciRah

Invite

A. Mauguen — researcher profile on SciRah